COMP250117P11000
- 0.00
- 0.000.00%
Compass Newsroom
Compass Point Says Innovative Industrial Needs 'Creativity' After Tenant Default
NCR Atleos Shares Rise After Compass Point Starts Coverage With Buy Rating
Compass Therapeutics Initiated With a Buy at D. Boral Capital
Compass Therapeutics Initiated at Buy by D. Boral Capital
Compass Therapeutics Price Target Announced at $32.00/Share by D. Boral Capital
Compass Point Initiates Coverage On NCR Atleos With Buy Rating, Announces Price Target of $57
Express News | Form 144 | Compass(COMP.US) Insider Proposes to Sell 17.7 Million in Common Stocks
Compass Point Downgrades Innovative Ind Props to Neutral, Lowers Price Target to $78
Compass Health Celebrates Second Donation From Longtime Partner for Its State-of-the-Art Regional Center for Intensive Behavioral Health Needs
Compass Mining Scales Texas Operations With 25 MW Bitcoin Mining Facility, Plans Further Expansion
American Express Price Target Raised to $325.00/Share From $315.00 by Compass Point
Institutional Investors in Compass Diversified (NYSE:CODI) Lost 4.3% Last Week but Have Reaped the Benefits of Longer-term Growth
Compass Point Adjusts Price Target on American Express to $325 From $315, Keeps Neutral Rating
Compass Minerals International Inc (CMP) Q4 2024 Earnings Call Highlights: Navigating ...
Compass Point Financial Analysts Hold an Analyst/industry Conference Call
BMO Capital Maintains Market Perform on Compass Minerals Intl, Lowers Price Target to $18
Compass Minerals Intl Analyst Ratings
Compass Group PLC Releases 2024 Annual Report and Sets 2025 AGM Date
Needham Maintains Compass(COMP.US) With Buy Rating, Raises Target Price to $10
Compass Pathways Common Stock To Be Added To The Nasdaq Biotechnology Index